Initial outcomes of a municipality-led prostate cancer screening program: Analysis of the osaka city system in a community clinic setting.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
Osaka City's prostate cancer screening at our clinic between fiscal years 2021 and 2025 were included
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Five men (8.3%) required further examination; one case was diagnosed with prostate cancer, and four had benign conditions. [CONCLUSIONS] This single-center descriptive study provides clinic-level data on the early implementation of a municipality-led prostate cancer screening program in Japan and may inform future evaluations and policy discussions regarding municipal screening initiatives.
[OBJECTIVE] In Japan, prostate cancer screening is primarily conducted under municipal administration.
APA
Yoshika M (2026). Initial outcomes of a municipality-led prostate cancer screening program: Analysis of the osaka city system in a community clinic setting.. Preventive medicine reports, 64, 103438. https://doi.org/10.1016/j.pmedr.2026.103438
MLA
Yoshika M. "Initial outcomes of a municipality-led prostate cancer screening program: Analysis of the osaka city system in a community clinic setting.." Preventive medicine reports, vol. 64, 2026, pp. 103438.
PMID
41852614
Abstract
[OBJECTIVE] In Japan, prostate cancer screening is primarily conducted under municipal administration. In 2021, Osaka City, Japan, launched a publicly funded program for prostate-specific antigen (PSA) testing. This study analyzed participation trends and referral rates in a community clinic, descriptively reporting early program implementation.
[METHODS] This retrospective observational study was conducted at a community clinic in Osaka City, Japan. Sixty men who underwent Osaka City's prostate cancer screening at our clinic between fiscal years 2021 and 2025 were included. Age-specific PSA cut-off values defined by the municipal program were applied. Changes in the number of examinees over time were descriptively summarized.
[RESULTS] The numbers of participants were 5 in 2021, 6 in 2022, 20 in 2023, 23 in 2024, and 6 in 2025. Five men (8.3%) required further examination; one case was diagnosed with prostate cancer, and four had benign conditions.
[CONCLUSIONS] This single-center descriptive study provides clinic-level data on the early implementation of a municipality-led prostate cancer screening program in Japan and may inform future evaluations and policy discussions regarding municipal screening initiatives.
[METHODS] This retrospective observational study was conducted at a community clinic in Osaka City, Japan. Sixty men who underwent Osaka City's prostate cancer screening at our clinic between fiscal years 2021 and 2025 were included. Age-specific PSA cut-off values defined by the municipal program were applied. Changes in the number of examinees over time were descriptively summarized.
[RESULTS] The numbers of participants were 5 in 2021, 6 in 2022, 20 in 2023, 23 in 2024, and 6 in 2025. Five men (8.3%) required further examination; one case was diagnosed with prostate cancer, and four had benign conditions.
[CONCLUSIONS] This single-center descriptive study provides clinic-level data on the early implementation of a municipality-led prostate cancer screening program in Japan and may inform future evaluations and policy discussions regarding municipal screening initiatives.